AbbVie to Present at the Bank of America Securities Healthcare Conference

NORTH CHICAGO, Ill., May 6, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Bank of America Securities Healthcare Conference on Wednesday, May 13, 2026.

PRNewsWire • May 6, 2026

6 Pharma Dividend Stocks Yielding Up to 6.44% — and They've Survived Every Market Crash

Dividend income arrives whether markets rally or sell off. For investors seeking recurring cash flow, high-yield equities remain the cleanest source outside a paycheck.

24/7 Wall Street • May 6, 2026

Want Reliable Dividend Income in May? These 2 Stocks Deliver

AbbVie is a Dividend King that has proven its ability to adapt. Realty Income is the ultimate monthly income play.

The Motley Fool • May 6, 2026

Is Trending Stock AbbVie Inc. (ABBV) a Buy Now?

AbbVie (ABBV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Zacks Investment Research • May 5, 2026

AbbVie Highlights New Long-Term Data Advancing Treatment Standards in Inflammatory Bowel Diseases (IBD) at 2026 Digestive Disease Week®

AbbVie presents 18 abstracts in Crohn's disease and ulcerative colitis Breadth of data from real-world evidence and clinical trials reinforce risankizumab and upadacitinib efficacy, safety profile, and durability NORTH CHICAGO, Ill., May 5, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the presentation of new data across its gastroenterology portfolio at the 2026 Digestive Disease Week (DDW) Annual Meeting, May 2-5 in Chicago.

PRNewsWire • May 5, 2026

AbbVie's Latest Results Reveal a Trend Investors Shouldn't Overlook

AbbVie posted strong first-quarter results. The company's two biggest growth drivers continue to exceed expectations.

The Motley Fool • May 4, 2026

ABBV Stock Up 5% on Robust Q1 Performance: Time to Buy, Sell or Hold?

AbbVie ABBV stock has risen around 5% since it announced robust first-quarter 2026 results on April 29. It beat estimates for both earnings and sales and the guidance for 2026 revenues and earnings was also raised.

Zacks Investment Research • May 4, 2026

10 Years, Zero Regrets: The Dividend Stocks I Keep Buying

Dividend stocks can be a pillar for long-term investing, generating passive income and offering stability even during tough environments.

24/7 Wall Street • May 4, 2026

3 of the Best Dividend Stocks to Buy in May 2026

The stocks pay between 3.4% and 5.9% in dividends. They trade at low earnings multiples.

The Motley Fool • May 4, 2026

The Most Important Part of These 3 Big Pharma Earnings Reports Wasn't the Beat

Earnings season is in full swing, and on April 29, three Big Pharma mainstays reported Q1 2026 earnings. Investors were looking for strong results—and strong guidance—that could serve as a sorely needed tailwind for the healthcare sector.

MarketBeat • May 2, 2026